Insider Transactions in Q2 2024 at Arcturus Therapeutics Holdings Inc. (ARCT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2024
|
Peter C Farrell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,131
+5.32%
|
-
|
|
Jun 14
2024
|
James F Barlow Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,131
+19.25%
|
-
|
|
Jun 14
2024
|
Magda Marquet Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,131
+50.0%
|
-
|
|
Jun 14
2024
|
John Markels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,131
+50.0%
|
-
|
|
Jun 14
2024
|
Edward W Holmes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,131
+50.0%
|
-
|
|
Jun 14
2024
|
Jing L. Marantz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,131
+50.0%
|
-
|
|
Jun 12
2024
|
Andy Sassine Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
50,000
-18.48%
|
$1,600,000
$32.03 P/Share
|
|
Jun 05
2024
|
Pad Chivukula Chief Scientific Officer & COO |
SELL
Open market or private sale
|
Direct |
114
-0.03%
|
$5,130
$45.0 P/Share
|
|
Jun 03
2024
|
Pad Chivukula Chief Scientific Officer & COO |
SELL
Open market or private sale
|
Direct |
26,000
-5.49%
|
$1,040,000
$40.01 P/Share
|